<DOC>
	<DOCNO>NCT02825043</DOCNO>
	<brief_summary>The primary objective study look correlation use HFNC outpatient set patient previous COPD exacerbation change BCSS score . The hypothesis home use HFNC lead reduction BCSS score 1.3 .</brief_summary>
	<brief_title>HFNC Effect BCSS Patients With COPD</brief_title>
	<detailed_description>This prospective pilot study . Targeted population include patient COPD , non-oxygen dependent , baseline normal bicarbonate previous lab ( within 6 month enrollment ) . Patients randomly select part study sample . Recruitment occur inpatient outpatient setting . An email briefly explain objective study send Internal Medicine resident Pulmonary Critical Care fellows help patient ' recruitment . Patients enrol study see Dr. Abdo Dr. Allen . The study expect finish end January 2017 twelve month post IRB approval . Patients recruit enrolled six month , collect data analyze six month last patient include study . The study target study sample 30 detailed statistical analysis section , patient control ( 3 month without HFNC follow 3 month HFNC ) .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>One previous COPD exacerbation last year . Can oxygen dependant PaCO2 &lt; 60</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>COPD</keyword>
</DOC>